$ 143.75+0.64 (+0.45%)
OpenPrice at market open
—LowLowest price today
—52-Week HighHighest past 52 weeks
—HighHighest price today
—52-Week LowLowest past 52 weeks
—Market Cap.Total company value
272.01BToday’s VolumeShares traded today
1.53MAvg. VolumeAverage shares traded
2.05MP/E RatioPrice to earnings ratio
21.52Company Profile
Novartis AG is a holding company, which engages in the business of developing, manufacturing, and marketing healthcare products. Its product portfolio is heavily focused on innovative prescription medicines, especially oncology, immunology, neuroscience, and cardiovascular diseases, supplemented by established older brands and a wide range of specialized therapies. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.
IPO Date
1996-11-07Headquarters
Basel, CHCEO
Vasant NarasimhanSector
HealthcareIndustry
Drug Manufacturers - GeneralFinancial Statements
Earnings
News

Ionis Delivers Positive Late-Stage Results for Two Partnered Drugs
16 days agoNVSzacks.com

Celldex Prepares For 2027 FDA Submission for Chronic Skin Disease
17 days agoNVSbenzinga.com

NVS Gets Positive CHMP Opinion for Cosentyx for Another Indication
18 days agoNVSzacks.com

Critical Analysis: Redhill Biopharma (NASDAQ:RDHL) versus Novartis (NYSE:NVS)
19 days agoNVSdefenseworld.net

Novartis halts ALS drug development after mid-stage trial failure
23 days agoNVSreuters.com

VanEck Pharmaceutical ETF vs VanEck Biotech ETF: Which Fund Is Better for Drug Innovation Profits?
24 days agoNVSfool.com
News
Related Companies
ABBVAbbVie Inc.
276.47
AZNAstraZeneca PLC
159.20
BMYBristol-Myers Squibb Company
59.12
GILDGilead Sciences, Inc.
151.17














